Neurocrine Biosciences says CEO to step down
Jan 14 (Reuters) - Neurocrine Biosciences Inc (NBIX.O) said Chief Executive Officer and President Gary Lyons will step down.
The company said it named Chief Operating Officer Kevin Gorman as CEO and president.
Lyons will continue to serve as a member of the board, the company said in a statement. (Reporting by Swagata Gupta in Bangalore; Editing by Vinu Pilakkott) ((swagata.gupta@reuters.com; within U.S. +1 646 223 8780; outside U.S. +91 80 4135 5800; Reuters Messaging: swagata.gupta.reuters.com@reuters.net))











